SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Company Response from Sonoma Pharmaceuticals, Inc. (SNOA) (CIK 0001367083) (SNOA) — Nov 21, 2017

Sonoma Pharmaceuticals, Inc. (SNOA) (CIK 0001367083)
Date: Nov. 21, 2017 · CIK: 0001367083 · Accession: 0001683168-17-003134

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-221477

Date
November 21, 2017
Author
/s/ Jim Schutz
Form
CORRESP
Company
Sonoma Pharmaceuticals, Inc. (SNOA) (CIK 0001367083)

Letter

VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance File No. 333-221477 Acceleration Request Requested Date: November 27, 2017 Requested Time: 4:00 P.M. EST

Re: Sonoma Pharmaceuticals, Inc.

Dear Mr. Edwards:

Pursuant to Rule 461 of the Rules and Regulations promulgated under the Securities Act of 1933, as amended, Sonoma Pharmaceuticals, Inc. (the “Company”), hereby requests that the above-captioned Registration Statement on Form S-3 (the “Registration Statement”) be accelerated to Monday, November 27, 2017 at 4:00 p.m. EST or as soon as practicable thereafter.

The cooperation of the staff in meeting our request is very much appreciated. Please call Amy Trombly at (617) 243-0060 if you have any questions or if we can otherwise be of assistance to you.

Very truly yours,
/s/ Jim Schutz

Show Raw Text
CORRESP
1
filename1.htm

November 21, 2017

VIA EDGAR

United States Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E., Mail Stop 3561

Washington, D.C. 20549

    Attn:
    Chris Edwards

    Re:
    Sonoma Pharmaceuticals, Inc.

    Registration Statement on Form S-3, as amended

Filed November 9, 2017, and amended on November
17, 2017

File No. 333-221477

    Acceleration Request

    Requested Date: November 27, 2017

    Requested Time: 4:00 P.M. EST

Dear Mr. Edwards:

Pursuant to Rule 461 of the Rules and Regulations
promulgated under the Securities Act of 1933, as amended, Sonoma Pharmaceuticals, Inc. (the “Company”), hereby requests
that the above-captioned Registration Statement on Form S-3 (the “Registration Statement”) be accelerated to Monday,
November 27, 2017 at 4:00 p.m. EST or as soon as practicable thereafter.

The cooperation of the staff in meeting
our request is very much appreciated. Please call Amy Trombly at (617) 243-0060 if you have any questions or if we can otherwise
be of assistance to you.

Very truly yours,

/s/ Jim Schutz

By: Jim Schutz

Chief Executive Officer

cc: Amy Trombly, Esq.